Home » Archive

Articles tagged with: clinical excellence

Featured, NHS Research News »

nhs news

A new £200 test could prevent huge numbers of women experiencing unnecessary chemotherapy by predicting whether their specific breast cancer could return post surgery.
Developed in Britain, the test will make use of technology widely used throughout NHS labs already, testing the recurrence chance of oestrogen positive (ER+) type breast cancer.
Currently, women diagnosed with ER+ type breast cancer will undergo surgery to remove the tumour before being treated with a hormone therapy in an attempt to combat remaining residual cancer. Hormone therapy also reduces the risk of recurrence.
Having assessed the tumour, …

Featured, NHS Research News »

medicine pills

In a blow for patients who are suffering from an advanced form of skin cancer, it has been announced that a new drug capable of treating it will not be made available on the NHS.
The drug is called ipilimumab and it has already been used in clinical trials. But it has a price tag of £80,000 for every patient treated with the drug. The National Institute for Health and Clinical Excellence (otherwise known as NICE) has issued guidance recommending that the NHS does not use the treatment. Furthermore the clinical …

Featured, NHS General News »

medicine pills

A new drug that’s been developed for those suffering from advanced stages of prostate cancer has been deemed ‘too expensive’ by the National Institute for Health and Clinical Excellence (NICE).
The drug, called cabazitaxel, has been proven to extend life for a period of around two months in those whom other treatments have stopped working.  It has only just been licensed in the UK, and is one which the Prostate Cancer Charity says is an important treatment that can allow men to spend precious extra time with their families.
However, at around …

Headline, NHS General News »

money for compensation

The UK is virtually the only country in Europe to decide that a new pill to combat Multiple Sclerosis (MS) simply costs too much.
The drug, fingolimod, which was given preliminary marketing approval by EU drugs regulators in January of this year, has been branded as “not a cost effective use of NHS resources” by the National Institute of Health and Clinical Excellence (NICE).
Current treatment for MS – known as interferon therapy – is administered by injection, either in hospital or by the patient themselves at home.  But this new pill …

Featured, NHS Research News »

nhs news

Findings from an audit across England and Wales suggest that the NHS faces a “diabetes time bomb.”
The report found that 800,000 diabetes patients have elevated blood sugar levels which could lead to kidney failure, limb amputation and stroke.
Alarmingly, many of the patients were young or middle aged and could need “substantial hospital care in a matter of years”. Nearly 300,000 people were at “high risk” and 144,000 were at “dangerously high risk” in the ‘under 55’ age category.
The National Institute for Health and Clinical Excellence (NICE) recommends those with diabetes …

Featured, NHS General News »

money for compensation

One in seven UK couples experience significant difficulty in conceiving, and IVF treatment is often their only chance of having children.  However, despite specific NHS guidelines to the contrary, over 70% of trusts are withholding treatment as a cost-cutting exercise.
The guidelines, developed by the National Institute for Health and Clinical Excellence (NICE), state that couples should be given up to three cycles if the woman is aged 23-39.
In March, Freedom of Information requests were sent out to PCT’s by The All Party Parliamentary Group.  Out of the 177 trusts, 171 …